Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Vertical Research Downgrades Paramount Global to Mixed

Vertical Research Downgrades Paramount Global to Mixed

Vertical Research downgrades Paramount Global (NASDAQ:PARA) from Positive to Mixed.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Vertical Research downgrades Paramount Global (NASDAQ:PARA) from Positive to Mixed.

Analyst Ratings

6 Analysts Assess Criteo: What You Need To Know

By Benzinga Insights

April 30, 11:00 AM

During the last three months, 6 analysts shared their evaluations of Criteo (NASDAQ:CRTO), revealing diverse outlooks from bullish…

CRTO

Axsome Therapeutics Announces Plans To Resubmit AXS-07 NDA Based On Successful FDA Type A Meeting; No Additional Clinical Efficacy Or Safety Trials Have Been Requested By The FDA For A Resubmission Of The NDA

By Benzinga Newsdesk

September 29, 7:12 AM

- Reuters

AXSM

Credit Suisse Maintains Outperform on Shoals Technologies Gr, Lowers Price Target to $20

By Benzinga Newsdesk

July 25, 9:14 AM

Credit Suisse analyst Maheep Mandloi maintains Shoals Technologies Gr (NASDAQ:SHLS) with a Outperform and lowers the price target from $25 to $20.

SHLS

Weibo, XPeng, Li Auto And Other Big Losers From Friday

By Lisa Levin

October 31, 5:44 AM

U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 800 points. Here is the list of some big stocks recording losses in the previous session.

ALRM

Vertical Research Downgrades Paramount Global to Mixed

Related Posts

6 Analysts Assess Criteo: What You Need To Know

Axsome Therapeutics Announces Plans To Resubmit AXS-07 NDA Based On Successful FDA Type A Meeting; No Additional Clinical Efficacy Or Safety Trials Have Been Requested By The FDA For A Resubmission Of The NDA

Credit Suisse Maintains Outperform on Shoals Technologies Gr, Lowers Price Target to $20

Weibo, XPeng, Li Auto And Other Big Losers From Friday